Your browser doesn't support javascript.
loading
Lipocalin 2 expression promotes tumor progression and therapy resistance by inhibiting ferroptosis in colorectal cancer.
Chaudhary, Nazia; Choudhary, Bhagya Shree; Shah, Sanket Girish; Khapare, Nileema; Dwivedi, Nehanjali; Gaikwad, Anagha; Joshi, Neha; Raichanna, Jinsy; Basu, Srikanta; Gurjar, Murari; P K, Smitha; Saklani, Avanish; Gera, Poonam; Ramadwar, Mukta; Patil, Prachi; Thorat, Rahul; Gota, Vikram; Dhar, Sujan K; Gupta, Sanjay; Das, Manjula; Dalal, Sorab N.
Afiliação
  • Chaudhary N; Cell and Tumor Biology, Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Tata Memorial Centre, Navi Mumbai, India.
  • Choudhary BS; Life Sciences, Homi Bhabha National Institute, Mumbai, India.
  • Shah SG; Cell and Tumor Biology, Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Tata Memorial Centre, Navi Mumbai, India.
  • Khapare N; Life Sciences, Homi Bhabha National Institute, Mumbai, India.
  • Dwivedi N; Life Sciences, Homi Bhabha National Institute, Mumbai, India.
  • Gaikwad A; Epigenetics and Chromatin Biology Group, Gupta Lab, Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Tata Memorial Centre, Navi Mumbai, India.
  • Joshi N; Cell and Tumor Biology, Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Tata Memorial Centre, Navi Mumbai, India.
  • Raichanna J; Tumor Immunology Program, Mazumdar Shaw Medical Foundation, Mazumdar Shaw Medical Centre, Narayana Health City, Bangalore, India.
  • Basu S; Cell and Tumor Biology, Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Tata Memorial Centre, Navi Mumbai, India.
  • Gurjar M; Cell and Tumor Biology, Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Tata Memorial Centre, Navi Mumbai, India.
  • P K S; Cell and Tumor Biology, Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Tata Memorial Centre, Navi Mumbai, India.
  • Saklani A; Cell and Tumor Biology, Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Tata Memorial Centre, Navi Mumbai, India.
  • Gera P; Department of Clinical Pharmacology, Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Tata Memorial Centre, Navi Mumbai, India.
  • Ramadwar M; Tumor Immunology Program, Mazumdar Shaw Medical Foundation, Mazumdar Shaw Medical Centre, Narayana Health City, Bangalore, India.
  • Patil P; Department of Gastrointestinal Oncology, Tata Memorial Hospital, Tata Memorial Centre, Mumbai, India.
  • Thorat R; Department of Biorepository, Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Tata Memorial Centre, Navi Mumbai, India.
  • Gota V; Department of Pathology, Tata Memorial Hospital, Tata Memorial Centre, Mumbai, India.
  • Dhar SK; Department of Digestive Disease and Clinical Nutrition, Tata Memorial Hospital, Tata Memorial Centre, Mumbai, India.
  • Gupta S; Laboratory Animal Facility, Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Tata Memorial Centre, Navi Mumbai, India.
  • Das M; Life Sciences, Homi Bhabha National Institute, Mumbai, India.
  • Dalal SN; Department of Clinical Pharmacology, Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Tata Memorial Centre, Navi Mumbai, India.
Int J Cancer ; 149(7): 1495-1511, 2021 10 01.
Article em En | MEDLINE | ID: mdl-34146401
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Biomarcadores Tumorais / Regulação Neoplásica da Expressão Gênica / Resistencia a Medicamentos Antineoplásicos / Fluoruracila / Lipocalina-2 Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Int J Cancer Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Índia País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Biomarcadores Tumorais / Regulação Neoplásica da Expressão Gênica / Resistencia a Medicamentos Antineoplásicos / Fluoruracila / Lipocalina-2 Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Int J Cancer Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Índia País de publicação: Estados Unidos